Business ❯Pharmaceutical Industry

Drug Development

Drug Development Pharmaceuticals Clinical Trials Pharmaceuticals Drug Development Drug Development Market Trends Investments Stock Market Obesity

U.S. Drug Launch Prices Skyrocket, Driven by Rare Disease Treatments

The median price of new drugs exceeded $370,000 in 2024, with single-dose gene therapies reaching as high as $4.25 million.

Trump Orders U.S. Drug Prices Tied to Lowest OECD Rates, Sparking Concerns Over Global Impact

Trump Expands Drug Pricing Model to Medicare and Medicaid, Targets Global Parity

Australia Subsidizes Esketamine Spray for Treatment-Resistant Depression

Eli Lilly's Oral GLP-1 Pill Demonstrates Success in Phase 3 Trials

EU Regulators Reject Eli Lilly's Alzheimer's Drug Over Safety Concerns

First Death Reported from Sarepta's Duchenne Gene Therapy Raises Safety Concerns

Parkinson’s and RLS Drug Linked to Risky Impulse Behaviors

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

FDA Approves Journavx, First Non-Opioid Painkiller in Over 20 Years

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock